Potential of Malawi’s medicinal plants in Covid-19 disease management: A review

Abstract

The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered an international pandemic that has led to significant public health problems. To date, limited evidence exists to suggest that drugs are effective against the disease. As possible treatments are being investigated, herbal medicines have shown potential for producing novel antiviral agents for the COVID-19 disease. Aim This review explored the potential of Malawi’s traditional medicinal plants for the management of COVID-19. MethodsThe authors searched on PubMed and Google scholar for medicinal plants that are used in Malawi and published in openly available peer reviewed journals. Plants linked with antiviral treatment, anti-COVID-19 activity or COVID-19 symptoms management were targeted. These included activity against pneumonia, inflammation, cough, difficulty in breathing, pain/aches, fever, diarrhoea, rheumatism, fatigue, asthma, immunocompromised and cardiovascular diseases.Results11 studies were found with 306 plant species. 127 plant species had at least one COVID-19 related pharmacological activity. Of these plant species, the number of herbal entities used for each indication was: pain/aches (87), fever (2), pneumonia (9), breathing/asthma problems (5), coughing (11), diarrhoea (1), immunosuppression (8), blood issues (10), fatigue (2), heart problems (11), inflammation (8), rheumatism (10) and viral diseases (12). Thirty (30) species were used for more than one disease and Azedarachta indica topped the list (6 of the 13 COVID-19 related diseases). The majority of the species had phytochemicals known to have antiviral activity or mechanisms of actions linked to COVID-19 and consequent diseases’ treatment pathways.ConclusionMedicinal plants are a promising source of compounds that can be used for drug development of COVID-19 related diseases. This review highlights potential targets for the World Health Organization and other research entities to explore in order to assist in controlling the pandemic.

Medicinal Uses of the Fabaceae Family in Zimbabwe: A Review

“…These species included Albizia amara, Albizia antunesiana, Brachystegia boehmii, Cassia abbreviate, Dichrostachys cinerea, Elephantorrhiza goetzei, Erythrina abyssinica, Peltophorum africanum, Piliostigma thonningii, Pterocarpus angolensis, Schotia brachypetala, Senna singueana, Vachellia karroo, Vigna unguiculata and Xeroderris stuhlmannii. Some of these plant species are widely used as sources of traditional medicines in Angola [ 63 ], Botswana [ 50 , 64 ], Eswatini [ 65 ], Malawi [ 66 , 67 ], Mozambique [ 58 , 68 ], Namibia [ 69 , 70 ], South Africa [ 71 , 72 ] and Zambia [ 73 , 74 ]. The importance of these species as sources of traditional medicines is documented in the monographs Medicinal and Magical Plants of Southern Africa: An Annotated Checklist [ 49 ], Plant Resources of Tropical Africa 11: Medicinal Plants 1 and 2 [ 75 , 76 ] and Medicinal Plants of South Africa [ 51 ].…”

Unlocking the anti‐diabetic potential of Gymnema sylvestre, Trigonella foenum‐graecum, and their combination thereof: An in‐vivo evaluation

“…Diabetes mellitus is a major problem in the world without any successful treatment. Plants are rich source of bioactive compounds and are being used as alternative medicines because of their potential to treat several diseases (Beressa et al, 2021 ; Chikowe et al, 2020 ; Chikowe et al, 2021 ; Mtewa et al, 2021 ) including diabetes (Bint Mustafa et al, 2016 ). There are many synthetic hypoglycemic agents available with several limitations and side effects.…”

COVID-19, the environment and animal life in Malawi compared to other countries: A brief scooping review for a research agenda in the developing countries

“…Like in other African countries such as Kenya and Madagascar, the increased demand for herbal supplements and other medicinal plants as treatment for the COVID-19 virus ( Chikowe et al, 2021 ; Malekmohammad and Rafieian-Kopaei, 2021 ) resulted into a surge of herbal productions in Malawi ( Kapatuka, 2020a ). While the situation brought a new window of herbal farming opportunity for farmers, land was anecdotally more stressed than before.…”